March 2, 2025 - 02:17
A recent study published in Clinical Diabetes highlights the potential of new diabetes technology to improve health outcomes for individuals with type 1 diabetes. Researchers from the University of Colorado Anschutz Medical Campus and Massachusetts General Hospital have found that when trained by a primary care provider or through telehealth, patients can effectively utilize the iLet Bionic Pancreas system. This technology, which was previously only examined in specialized endocrinology settings, shows promise in broadening access to care for those who may have difficulty visiting a specialist.
The findings suggest that integrating advanced diabetes management tools into primary care can empower patients to manage their condition more effectively. This approach not only enhances the quality of care but also addresses barriers faced by many individuals in accessing specialized diabetes treatment. By leveraging telehealth and training from primary care providers, the iLet Bionic Pancreas system could become a vital resource in improving the lives of those living with type 1 diabetes.
